Tumor hybrid cells in non-small cell lung cancer: population structure and contribution to prognosis
- Autores: Khozyainova A.A.1, Menyailo M.E.1, Tretyakova M.S.1, Bokova U.A.1, Korobeynikova A.A.1, Gerashchenko T.S.1, Rodionov E.O.1, Miller S.V.1, Denisov E.V.1
-
Afiliações:
- Tomsk National Research Medical Center
- Edição: Volume 28, Nº 4 (2024): ONCOLOGY
- Páginas: 439-451
- Seção: ONCOLOGY
- URL: https://journal-vniispk.ru/2313-0245/article/view/319737
- DOI: https://doi.org/10.22363/2313-0245-2024-28-4-439-451
- EDN: https://elibrary.ru/GPDHAP
- ID: 319737
Citar
Texto integral
Resumo
Relevance. Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide due to the high recurrence and metastasis rates. It is generally accepted that metastases and recurrences are formed by tumor cells with a highly invasive, stem and chemoresistant phenotype. Tumor hybrid cells (THCs) formed by the fusion of tumor cells with a wide range of normal cells: macrophages, fibroblasts, mesenchymal stem cells, etc. are considered to be potential metastasis and recurrence-initiating cells. However, the phenotypic diversity of THCs, and their association with disease progression remain poorly understood. The aim of the study was to characterize the population composition of THCs in NSCLC and its association with clinicopathological characteristics, metastasis and recurrence. Materials and Methods. A total of 50 patients with NSCLC were included. Fresh frozen samples of tumor tissue obtained during resection and morphologically verified were used to analyze types and number of THCs. THCs were analyzed by flow cytometry in primary tumors using markers for tumor cells, cancer stem cells, leukocytes, macrophages and fibroblasts. Results and Discussion. THCs were detected in all NSCLC patients. Most THCs demonstrated leukocyte, macrophage and stem characteristics. The number and frequency of THCs depended on neoadjuvant chemotherapy. THCs with leukocyte and stem cell markers (pan-CK+CD45+CD44+CD73+) were associated with locoregional recurrence, whereas THCs with macrophage and stem cell markers (EpCAM+CD45+CD44+CD73+CD163+) — with distant metastases. Conclusion. This study is the first to comprehensively describe the population composition of THCs in NSCLC, their association with clinicopathological characteristics, neoadjuvant chemotherapy and disease prognosis. Detection of prognostically relevant THCs could be an effective approach for predicting the risk of metastasis and recurrence of NSCLC and the basis for the development of therapy focused on the prevention of cancer progression.
Palavras-chave
Sobre autores
Anna Khozyainova
Tomsk National Research Medical Center
Email: max89me@yandex.ru
ORCID ID: 0000-0002-5475-5981
Código SPIN: 4201-0611
Tomsk, Russian Federation
Maxim Menyailo
Tomsk National Research Medical Center
Autor responsável pela correspondência
Email: max89me@yandex.ru
ORCID ID: 0000-0003-4630-4934
Código SPIN: 6929-4298
Tomsk, Russian Federation
Maria Tretyakova
Tomsk National Research Medical Center
Email: max89me@yandex.ru
ORCID ID: 0000-0002-5040-931X
Código SPIN: 5207-8330
Tomsk, Russian Federation
Ustinia Bokova
Tomsk National Research Medical Center
Email: max89me@yandex.ru
ORCID ID: 0000-0003-2179-5685
Código SPIN: 3546-0527
Tomsk, Russian Federation
Anastasia Korobeynikova
Tomsk National Research Medical Center
Email: max89me@yandex.ru
ORCID ID: 0000-0002-2633-9884
Código SPIN: 5523-8156
Tomsk, Russian Federation
Tatiana Gerashchenko
Tomsk National Research Medical Center
Email: max89me@yandex.ru
ORCID ID: 0000-0002-7283-0092
Código SPIN: 7900-9700
Tomsk, Russian Federation
Evgeny Rodionov
Tomsk National Research Medical Center
Email: max89me@yandex.ru
ORCID ID: 0000-0003-4980-8986
Código SPIN: 7650-2129
Tomsk, Russian Federation
Sergey Miller
Tomsk National Research Medical Center
Email: max89me@yandex.ru
ORCID ID: 0000-0002-5365-9840
Código SPIN: 6510-9849
Tomsk, Russian Federation
Evgeny Denisov
Tomsk National Research Medical Center
Email: max89me@yandex.ru
ORCID ID: 0000-0003-2923-9755
Código SPIN: 9498-5797
Tomsk, Russian Federation
Bibliografia
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209–249. doi: https://doi.org/10.3322/caac.21660
- Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. doi: 10.1038/nature25183
- Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR, Feuer EJ. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020;383(7):640–649. doi: 10.1056/NEJMoa1916623
- Mittal V. Epithelial Mesenchymal Transition in Tumor Metastasis. Annual Review of Pathology: Mechanisms of Disease. 2018;13(1):395–412. doi: 10.1146/annurev-pathol-020117-043854
- Huang Z, Zhang Z, Zhou C, Liu L, Huang C. Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. MedComm. 2022;3(2): e144. doi: https://doi.org/10.1002/mco2.144
- Kondratyuk RB, Grekov IS, Seleznev EA. Microenvironment influence on the development of epithelialmesenchymal transformation in lung cancer. RUDN Journal of Medicine. 2022;26(3):325–337. (in Russian). doi: 10.22363/2313-0245-2022-26-3-325-337.
- Menyailo ME, Tretyakova MS, Denisov EV. Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds. Int J Mol Sci. 2020;21(5):1696. doi: 10.3390/ijms21051696
- Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, Chrystel I, Morandi U, Stella F, Dominici M, Haider KH. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel). 2022;14(4):976. doi: 10.3390/cancers14040976
- Ye X, Huang X, Fu X, Zhang X, Lin R, Zhang W, Zhang J, Lu Y. Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis. Journal of Hematology & Oncology. 2023;16(1):46. doi: 10.1186/s13045-023-01442-4
- Montalbán-Hernández K, Cantero-Cid R, Casalvilla-Dueñas JC, Avendaño-Ortiz J, Marín E, Lozano-Rodríguez R, Terrón-Arcos V, Vicario-Bravo M, Marcano C, Saavedra-Ambrosy J, Prado- J, Valentín J, Pérez de Diego R, Córdoba L, Pulido E, del Fresno C, Dueñas M, López-Collazo E. Colorectal Cancer Stem Cells Fuse with Monocytes to Form Tumour Hybrid Cells with the Ability to Migrate and Evade the Immune System. Cancers. 2022;14(14):3445. doi: 10.3390/cancers14143445
- Scemama A, Lunetto S, Tailor A, Di Cio S, Ambler L, Coetzee A, Cottom H, Khurram SA, Gautrot J, Biddle A. Hybrid cancer stem cells utilise vascular tracks for collective streaming invasion in a metastasis-on-a-chip device. bioRxiv. 2024;2024.01.02.573897. doi: 10.1101/2024.01.02.573897
- Dörnen J, Sieler M, Weiler J, Keil S, Dittmar T. Cell Fusion-Mediated Tissue Regeneration as an Inducer of Polyploidy and Aneuploidy. Int J Mol Sci. 2020;21(5):1811. doi: 10.3390/ijms21051811
- Sutton TL, Walker BS, Wong MH. Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers. Cellular and Molecular Gastroenterology and Hepatology. 2019;8(4):595–607. doi: https://doi.org/10.1016/j.jcmgh.2019.07.002
- Tretyakova MS, Subbalakshmi AR, Menyailo ME, Jolly MK, Denisov EV. Tumor Hybrid Cells: Nature and Biological Significance. Frontiers in Cell and Developmental Biology. 2022;10:814714. doi: 10.3389/fcell.2022.814714
- Zhang LN, Huang YH, Zhao L. Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway. Arch Biochem Biophys. 2019;676:108137. doi: 10.1016/j.abb.2019.108137
- Lartigue L, Merle C, Lagarde P, Delespaul L, Lesluyes T, Le Guellec S, Pérot G, Leroy L, Coindre JM, Chibon F. Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread. Oncogene. 2020; 39(21):4198–4211. doi: 10.1038/s41388-020-1276-6
- Gast CE, Silk AD, Zarour L, Riegler L, Burkhart JG, Gustafson KT, Parappilly MS, Roh-Johnson M, Goodman JR, Olson B, Schmidt M, Swain JR, Davies PS, Shasthri V, Iizuka S, Flynn P, Watson S, Korkola J, Courtneidge SA, Fischer JM, Jaboin J, Billingsley KG, Lopez CD, Burchard J, Gray J, Coussens LM, BC, Wong MH. Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv. 2018;4(9): eaat7828. doi: 10.1126/sciadv.aat7828
- Aguirre LA, Montalbán-Hernández K, Avendaño-Ortiz J, Marín E, Lozano R, Toledano V, Sánchez-Maroto L, Terrón V, Valentín J, Pulido E, Casalvilla JC, Rubio C, Diekhorst L, Laso-García F, Del Fresno C, Collazo-Lorduy A, Jiménez-Munarriz B, Gómez-Campelo P, Llanos-González E, Fernández-Velasco M, Rodríguez-Antolín C, Pérez de Diego R, Cantero-Cid R, Hernádez-Jimenez E, Álvarez E. Rosas R, Dies López-Ayllón B, de Castro J, Wculek SK, Cubillos-Zapata C, Ibáñez de Cáceres I, Díaz-Agero P, Gutiérrez Fernández M, Paz de Miguel M, Sancho D, Schulte L, Perona R, Belda-Iniesta C, Boscá L, López-Collazo E. Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells. Oncoimmunology. 2020;9(1):1773204. doi: 10.1080/2162402x.2020.1773204
- Ye N, Cai J, Dong Y, Chen H, Bo Z, Zhao X, Xia M, Han M. A multi-omic approach reveals utility of CD45 expression in prognosis and novel target discovery. Frontiers in Genetics. 2022;13: 928328. doi: 10.3389/fgene.2022.928328
- Chen Y, Cui T, Yang L, Mireskandari M, Knoesel T, Zhang Q, Pacyna-Gengelbach M, Petersen I. The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer. Oncology. 2011;80(5–6):333–40. doi: 10.1159/000329098
- Kim Y, Kim HS, Cui ZY, Lee HS, Ahn JS, Park CK, Park K, Ahn MJ. Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung. Anticancer Res. 2009;29(5):1817–22.
- Han C, Liu T, Yin R. Biomarkers for cancer-associated fibroblasts. Biomarker Research. 2020;8(1):64. doi: 10.1186/s40364-020-00245-w
- Kahounová Z, Kurfürstová D, Bouchal J, Kharaishvili G, Navrátil J, Remšík J, Šimečková Š, Študent V, Kozubík A, Souček K. The fibroblast surface markers FAP, anti-fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial-to-mesenchymal transition. Cytometry A. 2018;93(9):941–951. doi: 10.1002/cyto.a.23101
- Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U. Cancer Stem Cells — Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Frontiers in Immunology. 2020;11:1280. doi: 10.3389/fimmu.2020.01280
- Ma XL, Hu B, Tang WG, Xie SH, Ren N, Guo L, Lu RQ. CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma. Journal of Hematology & Oncology. 2020;13(1):1–16. doi: 10.1186/s13045-020-0845-z
- Rakaee M, Busund LR, Jamaly S, Paulsen EE, Richardsen E, Andersen S, Al-Saad S, Bremnes RM, Donnem T, Kilvaer TK. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry. Neoplasia. 2019;21(3):282–293. doi: 10.1016/j.neo.2019.01.005
- Shabo I, Midtbö K, Andersson H, Åkerlund E, Olsson H, Wegman P, Gunnarsson C, Lindström A. Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction. BMC Cancer. 2015;15(1):922. doi: 10.1186/s12885-015-1935-0
- Pfannschmidt J. Editorial on “Long-term survival outcome after postoperative recurrence of non-small cell lung cancer: who is ‘cured’ from postoperative recurrence?”. J Thorac Dis. 2018;10(2):610–613. doi: 10.21037/jtd.2018.01.02
- Sekihara K, Hishida T, Yoshida J, Oki T, Omori T, Katsumata S, Ueda T, Miyoshi T, Goto M, Nakasone S, Ichikawa T, Matsuzawa R, Aokage K, Goto K, Tsuboi M. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is ‘cured’ from postoperative recurrence? Eur J Cardiothorac Surg. 2017;52(3):522–528. doi: 10.1093/ejcts/ezx127
- Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg. 2013;145(1):75–81. doi: 10.1016/j.jtcvs.2012.09.030
- Chitwood CA, Dietzsch C, Jacobs G, McArdle T, Freeman BT, Banga A, Noubissi FK, Ogle BM. Breast tumor cell hybrids form spontaneously in vivo and contribute to breast tumor metastases. APL Bioeng. 2018;2(3):031907. doi: 10.1063/1.5024744
- Manjunath Y, Mitchem JB, Suvilesh KN, Avella DM, Kimchi ET, Staveley-O’Carroll KF, Deroche CB, Pantel K, Li G, KaifiJT. Circulating Giant Tumor-Macrophage Fusion Cells Are Independent Prognosticators in Patients With NSCLC. Journal of Thoracic Oncology. 2020;15(9):1460–1471. doi: https://doi.org/10.1016/j.jtho.2020.04.034
- Xu MH, Gao X, Luo D, Zhou XD, Xiong W, Liu GX. EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells. PLoS One. 2014;9(2): e87893. doi: 10.1371/journal.pone.0087893
- Ding J, Jin W, Chen C, Shao Z, Wu J. Tumor associated macrophage× cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PloS one. 2012;7(7): e41942. 10.1371/journal.pone.0041942
- Menyailo ME, Zainullina VR, Khozyainova AA, Tashireva LA, Zolotareva SY, Gerashchenko TS, Alivanov VV, Savelieva OE, Grigoryeva ES, Tarabanovskaya NA, Popova NO, Choinzonov EL, Cherdyntseva NV, Perelmuter VM, Denisov EV. Heterogeneity of Circulating Epithelial Cells in Breast Cancer at Single-Cell Resolution: Identifying Tumor and Hybrid Cells. Advanced Biology. 2023;7(2):2200206. doi: 10.1002/adbi.202200206
- Anderson AN, Conley P, Klocke CD, Sengupta SK, Robinson TL, Fan Y, Jones JA, Gibbs SL, Skalet AH, Wu G, Wong MH. Analysis of uveal melanoma scRNA sequencing data identifies neoplastic-immune hybrid cells that exhibit metastatic potential. bioRxiv. 2023;10. doi: 10.1101/2023.10.24.563815
Arquivos suplementares
